| Dr Kishorchandra R Gonsai, MD | |
|
950 Campbell Ave, Bulding # 36, West Haven, CT 06516-2770 | |
| (203) 932-5711 | |
| (203) 937-3478 |
| Full Name | Dr Kishorchandra R Gonsai |
|---|---|
| Gender | Male |
| Speciality | Psychiatry & Neurology - Addiction Psychiatry |
| Location | 950 Campbell Ave, West Haven, Connecticut |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043308760 | NPI | - | NPPES |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Kishorchandra R Gonsai, MD 44 Cobblestone Dr, Hamden, CT 06518-1749 Ph: (203) 248-7347 | Dr Kishorchandra R Gonsai, MD 950 Campbell Ave, Bulding # 36, West Haven, CT 06516-2770 Ph: (203) 932-5711 |
News Archive
The use of general anesthesia is a routine part of surgical operations at hospitals and medical facilities around the world, but the precise biological mechanisms that underlie anesthetic drugs' effects on the brain and the body are only beginning to be understood. A review article in the December 30 New England Journal of Medicine brings together for the first time information from a range of disciplines, including neuroscience and sleep medicine, to lay the groundwork for more comprehensive investigations of processes underlying general anesthesia.
AbbVie, a research-based global biopharmaceutical company, today announced it submitted a supplemental New Drug Application to the U.S. Food and Drug Administration for venetoclax in combination with a hypomethylating agent or in combination with low-dose cytarabine for the treatment of newly diagnosed patients with acute myeloid leukemia who are ineligible for intensive chemotherapy.
More than a quarter of over 70s with type 2 diabetes could benefit simply from improving communication and education in the clinic, new research has revealed. A study led by the University of Exeter Medical School and published in The Lancet found that 27 percent achieved better glycaemic control through individualised care alone.
NeurogesX, Inc., a biopharmaceutical company focused on developing and commercializing novel pain management therapies, today announced plans to pursue a U.S. label expansion for Qutenza® (capsaicin) 8% patch to include patients with painful HIV-associated neuropathy (HIV-AN, also referred to as HIV-distal sensory polyneuropathy (HIV-DSP)).
› Verified 2 days ago
Dr. Robert Alan Rosenheck, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 950 Campbell Ave., West Haven, CT 06516 Phone: 203-937-3850 Fax: 203-937-3433 | |
Dr. Kathleen Louise Broad, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 950 Campbell Ave, Room 151d, West Haven, CT 06516 Phone: 203-932-5711 | |
Dr. Eric Dietrich Hermes, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 950 Campbell Ave # 151d, Bldg. 35 (lower Level), West Haven, CT 06516 Phone: 203-930-5711 | |
Juan Joseph Young, M.D. Psychiatry & Neurology Medicare: May Accept Medicare Assignments Practice Location: 950 Campbell Ave, West Haven, CT 06516 Phone: 203-932-5711 | |
Dr. Hamada Hamid Altalib, D.O.,M.P.H. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 950 Campbell Ave, Neurology-125, West Haven, CT 06516 Phone: 203-937-4724 | |
Dr. Mohini Ranganathan, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 950 Campbell Ave, Psychiatry Service/116a, West Haven, CT 06516 Phone: 203-932-5711 |